To evaluate the incidence of SARS-CoV-2 within the asymptomatic Congolese population, a seroprevalence study was conducted in different districts of Brazzaville. The study, just published on International Journal of Infectious Disease*, provided the proportion of the population who seroconvert over the course of the first wave as an important data to predict the risk of future COVID-19 waves and this will facilitate the efficient use of limited resources in low income country like the Republic of Congo.
This project was funded by European & Developing Countries Clinical Trials Partnership – EDCTP, through the African-European research network PANDORA-ID-Net (EDCTP Grant Agreement RIA2016E-1609) and ITAIL-COVID-19 (EDCTP Grant Agreement RIA2020EF-2947). Prof Francine Ntoumi is member of both CANTAM (EDCTP Grant Agreement RegNet2015-1045) and PANDORA-ID-Net networks.
*Batchi-Bouyou AL, Lobaloba L, Ndounga M, Vouvoungui JC, Mfoutou CM, Boumpoutou KR, Ntoumi F, High SARS-COV2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo, International Journal of Infectious Diseases (2020), doi: https://doi.org/10.1016/j.ijid.2020.12.065